January 23, 2026 — Leads & Copy — Agilent Technologies Inc. (NYSE: A) has launched the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, for sale in key European markets.
The launch signifies Agilent’s continued investment in digital pathology. It also expands its portfolio to meet the growing demand for high-throughput solutions in clinical laboratories.
Pathology laboratories face increasing pressure to improve diagnostic precision and operational efficiency while managing growing sample volumes and case complexity. Labs require robust, high-speed scanning solutions that integrate seamlessly into existing workflows. Reliance on traditional glass slide workflows alone can slow turnaround times and overall output. Workflow digitization and AI-driven tools have been proven to be key drivers of workflow efficiency and scalability.
The Agilent S540MD offers capacity for up to 540 slides, continuous loading, and standard rack compatibility. The scanner features automated scanning modes and AI-assisted tissue detection, enabling high-volume pathology labs to digitize glass slides efficiently and to implement digital and AI-driven workflows. The new scanner is the Agilent-branded version of the Hamamatsu NanoZoomer S540MD Slide Scanner System.
The Agilent S540MD scanner enhances Agilent’s capabilities in digital pathology, enriching its offering from staining to AI decision support. It also provides laboratories with increased flexibility to select solutions that align with their specific requirements.
Nina Green, vice president and general manager of the clinical diagnostics division at Agilent, said the introduction of the Agilent S540MD Slide Scanner System marks an important advancement in Agilent’s commitment to equip pathology laboratories with advanced digital technologies. Green said this initiative facilitates the acceleration of diagnostic workflows and supports improved patient outcomes.
Green also stated that Agilent’s partnership with Hamamatsu demonstrates its ongoing dedication to delivering integrated, fully interoperable solutions to address the evolving needs of clinical laboratories.
The Agilent S540MD scanner will initially be available as IVD in Germany, France, Belgium, Spain, Austria, Luxembourg, and Italy (IVDR), the UK (MDR2002) and Switzerland (IvDO) with plans to expand into additional European countries and further milestones are scheduled for 2026.
Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies. Agilent’s full range of solutions includes instruments, software, services, and expertise. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide.
For more information about Agilent’s digital pathology solutions, visit https://www.agilent.com/en/product/digital-pathology.
Source: Agilent Technologies
